Treatment of Disseminated Intravenous Leiomyomatosis With ALK Targeting Crizotinib: A Successful Case Report

JCO Precis Oncol. 2022 Feb;6:e2100336. doi: 10.1200/PO.21.00336.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anaplastic Lymphoma Kinase / genetics
  • Carcinoma, Non-Small-Cell Lung*
  • Crizotinib / therapeutic use
  • Humans
  • Leiomyomatosis* / drug therapy
  • Lung Neoplasms*

Substances

  • Crizotinib
  • Anaplastic Lymphoma Kinase